Revolution Medicines
RVMD
About Revolution Medicines
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical…
RVMD Key Financials
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
RVMD Analysis Tools & Insights
What If Invested
What if you had invested $1,000? See historical returns from any date.
How it makes money
Discover visual breakdown — where revenue comes from and where it goes.
Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
Price target scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
Daily Price Character
Explosive · 50.7% historical win rate (green days). Streaks & record days.
Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.